SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-19-000057
Filing Date
2019-12-06
Accepted
2019-12-06 17:26:02
Documents
14
Period of Report
2019-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20191205form8xk.htm   iXBRL 8-K 50429
  Complete submission text file 0001280600-19-000057.txt   193169

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20191205.xsd EX-101.SCH 4603
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20191205_cal.xml EX-101.CAL 634
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20191205_def.xml EX-101.DEF 1484
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20191205_lab.xml EX-101.LAB 26142
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20191205_pre.xml EX-101.PRE 13590
14 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20191205form8xk_htm.xml XML 4483
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 191273882
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences